Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Shirabe

Showing results (401-410 of 834) with videos related to

Pageof 84
Sort By:
Oncology|March 5, 2011
Significance of DNA polymerase delta catalytic subunit p125 induced by mutant p53 in the invasive potential of human hepatocellular carcinomaKensaku Sanefuji, Akinobu Taketomi, Tomohiro Iguchi, et al.
Surgery Today|December 28, 2011
Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysisShinji Itoh, Ken Shirabe, Akinobu Taketomi, et al.
Transplantation|April 20, 2013
Obstructing spontaneous major shunt vessels is mandatory to keep adequate portal inflow in living-donor liver transplantationToru Ikegami, Ken Shirabe, Hidekazu Nakagawara, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 16, 2014
Clinical outcomes of living donor liver transplantation for patients 65 years old or older with preserved performance statusToru Ikegami, Yuki Bekki, Daisuke Imai, et al.
Cancer Science|March 5, 2015
Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesisHideyuki Konishi, Ken Shirabe, Hidekazu Nakagawara, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 17, 2015
Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantationYo-Ichi Yamashita, Yoshihiro Yoshida, Takeshi Kurihara, et al.
Hepato-Gastroenterology|June 27, 2007
Characteristic gene expression induced by polyurethane foam/spheroid culture of hepatoma cell line, Hep G2 as a promising cell source for bioartificial liverMitsuo Shimada, Yo-ichi Yamashita, Shinji Tanaka, et al.
Cell Transplantation|August 7, 2002
High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failureYo-ichi Yamashita, Mitsuo Shimada, Eiji Tsujita, et al.
Journal of the American College of Surgeons|December 3, 2014
Long-term favorable surgical results of laparoscopic hepatic resection for hepatocellular carcinoma in patients with cirrhosis: a single-center experience over a 10-year periodYo-ichi Yamashita, Tetsuo Ikeda, Takeshi Kurihara, et al.
Anticancer Research|July 31, 2014
Living donor liver transplantation followed by total gastrectomy--a two-stage planed operative strategy for early gastric cancer concomitant with decompensated liver cirrhosisSho Nishimura, Hiroshi Saeki, Toru Ikegami, et al.
Pageof 84

Showing results (401-410 of 834) with videos related to

Sort By:
Pageof 84
Oncology|March 5, 2011
Significance of DNA polymerase delta catalytic subunit p125 induced by mutant p53 in the invasive potential of human hepatocellular carcinomaKensaku Sanefuji, Akinobu Taketomi, Tomohiro Iguchi, et al.
Surgery Today|December 28, 2011
Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysisShinji Itoh, Ken Shirabe, Akinobu Taketomi, et al.
Transplantation|April 20, 2013
Obstructing spontaneous major shunt vessels is mandatory to keep adequate portal inflow in living-donor liver transplantationToru Ikegami, Ken Shirabe, Hidekazu Nakagawara, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 16, 2014
Clinical outcomes of living donor liver transplantation for patients 65 years old or older with preserved performance statusToru Ikegami, Yuki Bekki, Daisuke Imai, et al.
Cancer Science|March 5, 2015
Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesisHideyuki Konishi, Ken Shirabe, Hidekazu Nakagawara, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 17, 2015
Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantationYo-Ichi Yamashita, Yoshihiro Yoshida, Takeshi Kurihara, et al.
Hepato-Gastroenterology|June 27, 2007
Characteristic gene expression induced by polyurethane foam/spheroid culture of hepatoma cell line, Hep G2 as a promising cell source for bioartificial liverMitsuo Shimada, Yo-ichi Yamashita, Shinji Tanaka, et al.
Cell Transplantation|August 7, 2002
High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failureYo-ichi Yamashita, Mitsuo Shimada, Eiji Tsujita, et al.
Journal of the American College of Surgeons|December 3, 2014
Long-term favorable surgical results of laparoscopic hepatic resection for hepatocellular carcinoma in patients with cirrhosis: a single-center experience over a 10-year periodYo-ichi Yamashita, Tetsuo Ikeda, Takeshi Kurihara, et al.
Anticancer Research|July 31, 2014
Living donor liver transplantation followed by total gastrectomy--a two-stage planed operative strategy for early gastric cancer concomitant with decompensated liver cirrhosisSho Nishimura, Hiroshi Saeki, Toru Ikegami, et al.
Pageof 84